Rojas et al. [51] demonstrated that an integrin marker composed of ITGA4, ITGB2, ITGAX, ITGB7, ITGAM, ITGAL, and ITGA8 had the potential to recognize basal-like breast cancers with immune-infiltrating and favorable prognosis. This evidence concerns the gene ITGAL and breast carcinoma.